Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:13:33.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study record with a generic error page. This change restricts access to the trial's details and related information.
    Difference
    17%
    Check dated 2026-09-20T01:26:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    There are no textual changes recorded for this page in the provided data; the page remains as published.
    Difference
    0.1%
    Check dated 2026-09-12T23:55:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    No additions or deletions are present; the study page content remains as listed with no changes detected.
    Difference
    0.1%
    Check dated 2026-09-05T22:39:33.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Added a 2016 ( U.S. NIH Grant/Contract ) note to the study identifiers. Updated the site revision label to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T21:51:46.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.4 to v3.6.5, indicating an updated version of the page. This is a metadata update rather than a modification to study content or functionality.
    Difference
    0.1%
    Check dated 2026-08-08T20:45:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.